Detalles de la búsqueda
1.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer
; 152(2): 267-275, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005450
2.
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
Breast Cancer Res Treat
; 198(1): 67-74, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624321
3.
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.
Intern Med J
; 52(10): 1707-1716, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002929
4.
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
Int J Cancer
; 149(2): 409-419, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729581
5.
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
Breast Cancer Res Treat
; 184(1): 87-95, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779037
6.
Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme.
Intern Med J
; 50(1): 99-104, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816606
7.
Visualization of Germination Proteins in Putative Bacillus cereus Germinosomes.
Int J Mol Sci
; 21(15)2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32707970
8.
Incidence, clinical implications and impact on public health of infections with Shigella spp. and entero-invasive Escherichia coli (EIEC): results of a multicenter cross-sectional study in the Netherlands during 2016-2017.
BMC Infect Dis
; 19(1): 1037, 2019 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31818261
9.
Evaluation of a Culture-Dependent Algorithm and a Molecular Algorithm for Identification of Shigella spp., Escherichia coli, and Enteroinvasive E. coli.
J Clin Microbiol
; 56(10)2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30021824
10.
Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
Ann Surg Oncol
; 25(9): 2563-2572, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29717421
11.
Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals' attitudes to and experience with scalp cooling.
Support Care Cancer
; 26(1): 305-312, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28852873
12.
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
Intern Med J
; 48(1): 37-44, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544061
13.
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 17(6): 811-821, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155741
14.
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.
Breast Cancer Res Treat
; 156(2): 319-30, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26993131
15.
Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.
J Clin Microbiol
; 53(5): 1588-98, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740764
16.
Is Shiga Toxin-Negative Escherichia coli O157:H7 Enteropathogenic or Enterohemorrhagic Escherichia coli? Comprehensive Molecular Analysis Using Whole-Genome Sequencing.
J Clin Microbiol
; 53(11): 3530-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26311863
17.
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
BMC Cancer
; 15: 171, 2015 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25881079
18.
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial.
Lancet Oncol
; 14(3): 228-35, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23414585
19.
Current usage of pembrolizumab in triple negative breast cancer (TNBC).
Expert Rev Anticancer Ther
; 24(5): 253-261, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594892
20.
Evaluating a Remotely Delivered Cardio-Oncology Rehabilitation Intervention for Patients With Breast Cancer (REMOTE-COR-B): Protocol for a Single-Arm Feasibility Trial.
JMIR Res Protoc
; 13: e53301, 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578682